tiprankstipranks
Trending News
More News >
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market
Advertisement

Alembic Pharmaceuticals Limited (APLLTD) Ratios

Compare
1 Followers

Alembic Pharmaceuticals Limited Ratios

IN:APLLTD's free cash flow for Q4 2025 was ₹0.70. For the 2025 fiscal year, IN:APLLTD's free cash flow was decreased by ₹ and operating cash flow was ₹0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.69 2.12 1.78 1.67 2.01
Quick Ratio
0.75 0.99 0.88 0.73 0.85
Cash Ratio
0.04 0.08 0.05 0.04 0.08
Solvency Ratio
0.33 0.55 0.34 0.43 0.81
Operating Cash Flow Ratio
0.00 0.55 0.44 0.32 1.14
Short-Term Operating Cash Flow Coverage
0.00 1.87 1.14 0.88 4.88
Net Current Asset Value
₹ 15.04B₹ 14.51B₹ 10.98B₹ 9.76B₹ 9.36B
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.08 0.12 0.10 0.09
Debt-to-Equity Ratio
0.24 0.11 0.17 0.14 0.11
Debt-to-Capital Ratio
0.20 0.10 0.14 0.12 0.10
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.04
Financial Leverage Ratio
1.50 1.34 1.41 1.36 1.31
Debt Service Coverage Ratio
0.73 1.94 1.02 1.27 4.16
Interest Coverage Ratio
17.42 10.25 8.73 33.13 80.95
Debt to Market Cap
0.06 0.02 0.07 0.04 0.03
Interest Debt Per Share
67.97 28.97 39.28 37.38 30.95
Net Debt to EBITDA
1.11 0.41 0.91 0.71 0.31
Profitability Margins
Gross Profit Margin
66.39%36.43%69.77%67.06%71.17%
EBIT Margin
11.54%11.05%7.16%12.29%26.23%
EBITDA Margin
15.76%15.44%12.58%17.67%29.71%
Operating Profit Margin
20.57%9.24%7.74%11.23%24.58%
Pretax Profit Margin
10.60%10.14%6.27%11.85%25.93%
Net Profit Margin
8.74%9.89%6.05%9.96%21.73%
Continuous Operations Profit Margin
8.72%9.89%6.60%9.96%21.73%
Net Income Per EBT
82.50%97.47%96.45%84.01%83.80%
EBT Per EBIT
51.54%109.73%81.00%105.56%105.49%
Return on Assets (ROA)
7.51%9.55%5.53%7.31%17.09%
Return on Equity (ROE)
11.80%12.78%7.83%9.95%22.36%
Return on Capital Employed (ROCE)
25.60%11.54%9.63%10.87%23.89%
Return on Invested Capital (ROIC)
17.19%10.32%8.12%8.07%18.41%
Return on Tangible Assets
7.51%9.55%5.53%7.48%17.95%
Earnings Yield
2.99%3.11%3.51%3.57%6.13%
Efficiency Ratios
Receivables Turnover
4.77 6.08 5.40 6.48 15.14
Payables Turnover
2.55 5.38 2.51 2.44 2.27
Inventory Turnover
0.98 2.41 1.16 1.07 1.02
Fixed Asset Turnover
1.99 2.03 1.88 1.33 1.45
Asset Turnover
0.86 0.97 0.91 0.73 0.79
Working Capital Turnover Ratio
7.96 4.30 4.68 4.29 5.25
Cash Conversion Cycle
305.82 143.74 237.48 247.65 220.23
Days of Sales Outstanding
76.58 60.06 67.57 56.31 24.11
Days of Inventory Outstanding
372.48 151.50 315.11 340.96 356.57
Days of Payables Outstanding
143.24 67.81 145.21 149.63 160.46
Operating Cycle
449.06 211.55 382.68 397.27 380.69
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 40.86 36.83 28.10 75.53
Free Cash Flow Per Share
0.00 24.20 14.27 6.45 41.49
CapEx Per Share
0.00 16.66 22.56 21.65 34.04
Free Cash Flow to Operating Cash Flow
0.00 0.59 0.39 0.23 0.55
Dividend Paid and CapEx Coverage Ratio
0.00 1.66 1.13 0.79 2.22
Capital Expenditure Coverage Ratio
0.00 2.45 1.63 1.30 2.22
Operating Cash Flow Coverage Ratio
0.00 1.57 1.00 0.77 2.51
Operating Cash Flow to Sales Ratio
0.00 0.13 0.13 0.11 0.28
Free Cash Flow Yield
0.00%2.40%2.88%0.87%4.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
33.46 32.20 28.53 27.98 16.31
Price-to-Sales (P/S) Ratio
2.93 3.18 1.73 2.79 3.54
Price-to-Book (P/B) Ratio
3.76 4.12 2.23 2.78 3.65
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 41.69 34.78 115.04 23.26
Price-to-Operating Cash Flow Ratio
0.00 24.69 13.48 26.39 12.78
Price-to-Earnings Growth (PEG) Ratio
-9.43 0.40 -0.83 -0.51 0.47
Price-to-Fair Value
3.76 4.12 2.23 2.78 3.65
Enterprise Value Multiple
19.68 21.03 14.63 16.48 12.24
Enterprise Value
206.85B 202.25B 104.03B 152.33B 191.81B
EV to EBITDA
19.68 21.03 14.63 16.48 12.24
EV to Sales
3.10 3.25 1.84 2.91 3.64
EV to Free Cash Flow
0.00 42.51 37.08 120.22 23.86
EV to Operating Cash Flow
0.00 25.18 14.37 27.58 13.11
Tangible Book Value Per Share
263.96 245.13 222.34 258.58 244.86
Shareholders’ Equity Per Share
264.03 245.13 222.34 266.46 264.66
Tax and Other Ratios
Effective Tax Rate
0.18 0.03 0.04 0.17 0.19
Revenue Per Share
339.37 316.88 287.57 266.16 272.33
Net Income Per Share
29.68 31.33 17.40 26.50 59.18
Tax Burden
0.83 0.97 0.96 0.84 0.84
Interest Burden
0.92 0.92 0.88 0.96 0.99
Research & Development to Revenue
0.00 0.07 <0.01 <0.01 <0.01
SG&A to Revenue
0.00 0.04 0.04 0.04 0.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 1.30 2.04 0.89 1.07
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis